E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4 Temporality:E24 Severity:T48
E5	Procedure:T5 Name:T6 Temporality:E27
E6	Eq-Comparison:T15 Operator:T7 Value:T12
E7	Eq-Comparison:T16 Operator:T8 Value:T13 Unit:T57 Per:T58
E8	Eq-Comparison:T17 Operator:T9 Value:T14 Unit:T59 Per:T60
E2	Procedure:T18 Temporality:E4
E4	Eq-Comparison:T19 Temporal-Recency:T20
E9	Procedure:T21 Name:T22 Minimum-Count:E10
E10	Eq-Comparison:T23 Value:T24
E11	Procedure:T25 Name:T26 Minimum-Count:E12
E12	Eq-Comparison:T27 Operator:T28
E13	Or:T29 Arg:E9 Arg2:E11
E14	Observation:T30 Name:T31 Eq-Comparison:E15
E15	Eq-Comparison:T32 Operator:T33 Value:T11 Temporal-Unit:T10
E16	Procedure:T34 Temporality:E18
E17	Procedure:T35 Name:T36
E18	Eq-Comparison:T37 Temporal-Recency:T38
E19	Temporal-Connection:T39 Arg:E15 Arg2:E18
E20	Condition:T40 Name:T42
E21	Allergy:T41 Name:E22
E22	Procedure:T43 Name:T44
E23	Or:T45 Arg:E20 Arg2:E21
E24	Eq-Comparison:T46 Temporal-Period:T47
E25	Observation:T49 Name:T50
E26	Observation:T51 Name:T52 Eq-Comparison:E6
E27	Eq-Comparison:T53 Temporal-Period:T54
E28	Drug:T55 Name:T56 Dose:E7
E29	Drug:T61 Name:T62 Dose:E8
E30	Drug:T63 Name:T64
E31	Or:T65 Arg:E28 Arg2:E30
E32	Drug:T66 Name:T67
E33	Drug:T68 Name:T69
E34	Drug:T70 Name:T71
E35	Drug:T72 Name:T73
E36	Drug:T74 Name:T75
E37	Drug:T76 Name:T77
E38	Drug:T78 Name:T79
E39	Drug:T80 Name:T81
E40	Drug:T82 Name:T83
E41	Drug:T84 Name:T85
E42	Drug:T86 Name:T87
E43	Drug:T88 Name:T89
E44	Or:T90 Arg:E42 Arg2:E43
T1	Condition 329 310	anaphylactic reaction
T2	Condition-Name 329 310	anaphylactic reaction
T3	Condition 391 368	autoimmune disease
T4	Condition-Name 391 368	autoimmune disease
T5	Procedure 536 503	immunosuppressive therapy
T6	Procedure-Name 536 503	immunosuppressive therapy
T7	Eq-Operator 490 461	≥
T8	Eq-Operator 560 526	>
T9	Eq-Operator 592 552	>
T10	Eq-Temporal-Unit 209 194	months
T11	Eq-Value 202 187	3
T12	Eq-Value 493 463	3
T13	Eq-Value 564 528	10
T14	Eq-Value 597 555	1.5
T15	Eq-Comparison 493 463	≥ 3
T16	Eq-Comparison 573 535	>10 mg/day
T17	Eq-Comparison 606 562	>1.5 mg/day
T18	Procedure 52 48	treatment
T19	Eq-Comparison 39 35	Initiation
T20	Eq-Temporal-Recency 39 35	Initiation
T21	Procedure 70 66	ICI
T22	Procedure-Name 70 66	ICI
T23	Eq-Comparison 66 62	single
T24	Eq-Value 66 62	single
T25	Procedure 95 91	ICIs
T26	Procedure-Name 95 91	ICIs
T27	Eq-Comparison 87 83	combination
T28	Eq-Operator 87 83	combination
T29	Or 73 69	or
T30	Observation 188 174	Life expectancy
T31	Observation-Name 188 174	Life expectancy
T32	Eq-Comparison 209 194	lower than 3 months
T33	Eq-Operator 199 185	lower than
T34	Procedure 242 227	treatment
T35	Procedure 252 237	ICIs
T36	Procedure-Name 252 237	ICIs
T37	Eq-Comparison 229 214	initiation
T38	Eq-Temporal-Recency 229 214	initiation
T39	Temporal-Connection 214 199	from
T40	Condition 286 267	hypersensitivity
T41	Allergy 307 288	allergic
T42	Condition-Name 286 267	hypersensitivity
T43	Procedure 355 336	ICI
T44	Procedure-Name 355 336	ICI
T45	Or 289 270	or
T46	Eq-Comparison 372 349	Active
T47	Eq-Temporal-Period 372 349	Active
T48	Severity 403 380	severe
T49	Observation 460 433	Eastern Cooperative Oncology Group
T50	Observation-Name 460 433	Eastern Cooperative Oncology Group
T51	Observation 467 439	ECOG
T52	Observation-Name 467 439	ECOG
T53	Eq-Comparison 510 477	Ongoing
T54	Eq-Temporal-Period 510 477	Ongoing
T55	Drug 549 515	prednisone
T56	Drug-Name 549 515	prednisone
T57	Eq-Unit 567 531	mg
T58	Eq-Temporal-Unit 573 535	day
T59	Eq-Unit 600 558	mg
T60	Eq-Temporal-Unit 606 562	day
T61	Drug 623 579	dexamethasone
T62	Drug-Name 623 579	dexamethasone
T63	Drug 662 613	azathioprine
T64	Drug-Name 662 613	azathioprine
T65	Or 637 588	and/or
T66	Drug 677 627	methotrexate
T67	Drug-Name 677 627	methotrexate
T68	Drug 693 642	mycophenolate
T69	Drug-Name 693 642	mycophenolate
T70	Drug 712 660	cyclophosphamide
T71	Drug-Name 712 660	cyclophosphamide
T72	Drug 726 673	leflunomide
T73	Drug-Name 726 673	leflunomide
T74	Drug 738 684	rituximab
T75	Drug-Name 738 684	rituximab
T76	Drug 775 718	anti-tumor necrosis factor drugs
T77	Drug-Name 775 718	anti-tumor necrosis factor drugs
T78	Drug 788 730	infliximab
T79	Drug-Name 788 730	infliximab
T80	Drug 801 742	etanercept
T81	Drug-Name 801 742	etanercept
T82	Drug 814 754	adalimumab
T83	Drug-Name 814 754	adalimumab
T84	Drug 826 765	golimumab
T85	Drug-Name 826 765	golimumab
T86	Drug 841 777	belimumab
T87	Drug-Name 841 777	belimumab
T88	Drug 855 791	abatacept
T89	Drug-Name 855 791	abatacept
T90	Or 845 781	and
A1	Eq-Operator-Value T7 GTEQ
A2	Eq-Operator-Value T8 GT
A3	Eq-Operator-Value T9 GT
A4	Eq-Temporal-Unit-Value T10 month
A5	Eq-Temporal-Recency-Value T20 first-time
A6	Eq-Operator-Value T28 GT
A7	Eq-Operator-Value T33 LT
A8	Eq-Temporal-Recency-Value T38 first-time
A9	Temporal-Connection-Type-Value E19 after
A10	Eq-Temporal-Period-Value T47 present
A11	Severity-Value T48 severe
A12	Observation-Type-Value T50 clinical-score
A13	Observation-Type-Value T52 clinical-score
A14	Eq-Temporal-Period-Value T54 present
A15	Eq-Temporal-Unit-Value T58 day
A16	Eq-Temporal-Unit-Value T60 day
R1	Using Arg1:E2 Arg2:E9
R2	Using Arg1:E2 Arg2:E11
R3	Using Arg1:E16 Arg2:E17
R4	Caused-By Arg1:E20 Arg2:E22
R5	Caused-By Arg1:E1 Arg2:E22
R6	Abbrev-Of Arg1:E26 Arg2:E25
R7	Equivalent-To Arg1:E29 Arg2:E28
R8	Example-Of Arg1:E38 Arg2:E37
R9	Example-Of Arg1:E39 Arg2:E37
R10	Example-Of Arg1:E40 Arg2:E37
R11	Example-Of Arg1:E41 Arg2:E37